Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation

Bone Marrow Transplantation

Volumn 31, Issue 6, 2003, Pages 437-440

  Rossi, G ^a   Giorgiani, G ^a   Comoli, P ^a   Nobili, B ^b   Salvaneschi, L ^c   De Stefano, P ^a   Maccario, R ^a   Locatelli, F ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Adoptive immunotherapy; Fanconi anaemia; Haploidentical stem cell transplantation; Immune recovery

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; CD34 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN; METHOTREXATE; MITOMYCIN C; PENICILLIN G; PYRIMETHAMINE; RECOMBINANT ALPHA2B INTERFERON; SULFADIAZINE; THYMOCYTE ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ALLOGRAFT; ARTICLE; BONE MARROW DEPRESSION; CASE REPORT; CHIMERA; DISEASE SEVERITY; DONOR; FANCONI ANEMIA; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; INFECTION PREVENTION; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; T LYMPHOCYTE;

CHILD; FANCONI ANEMIA; FEMALE; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ADOPTIVE; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; VIDARABINE;

EID: 0037368637     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703903     Document Type: Article

References (25)

1. Auerbach AD, Buchwald M, Joenje H. Fanconi Anemia. In: Vogelstein, Kinzler KW (eds). The Genetic Basis of Human Cancer. McGraw-Hill: New York, 1997, p 317.
2. Butturini A, Gale RP, Verlander PC et al. Hematologic abnormalities in Fanconi anaemia: an international Fanconi anemia registry study. Blood 1994; 90: 105-110.
3. Gluckman E, Auerbach AD, Horowitz MM et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86: 2856-62.
4. Dufour C, Rondelli R, Locatelli F et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP)-Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol 2001; 112: 796-806.
5. Guardiola P, Pasquini R, Dokal I et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi Anaemia using HLA-matched unrelated donors. A study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422-429.
6. Davies SM, Khan S, Wagner JE et al. Unrelated donor bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 1996; 17: 43-47.
7. Berger R, Bemheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolities on chromosomes of Fanconi's anaemia patients. Br J Haematol 1980; 45: 565-568.
8. Gluckman E, Devergie A, Dutriex J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431-440.
9. Fisher A, Friedrich W, Fasth A et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anaemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood 1991; 77: 249-256.
10. Boulad F, Gillio A, Small TN et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive reductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000; 111: 1153-1157.
11. Elhasid R, Weyl Ben Arush M, Katz T et al. Successful haploidentical bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant 2000; 26: 1221-1223.
12. Locatelli F, Maccario R, Grossi P et al. Disseminated toxoplasmosis in a recipient of T cell depleted partially matched bone marrow transplant. Int J Ped Haematol Oncol 1993; 1: 247-252.
13. Stevens SJC, Verschuuren EAM, Pronk I et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in high-risk patients. Blood 2001; 97: 1165-1171.
14. Comoli P, Labirio M, Basso S et al. Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood 2002; 99: 2592-2598.
15. Kohli-Kumar M, Morris C, Delaat C et al. Bone marrow transplantation in Fanconi anaemia using matched sibling donors. Blood 1994; 84: 2050-2054.
16. Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531-4536.
17. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic disease. Blood 1998; 91: 756-763.
18. Aker M, Varadi G, Slavin S, Nagler A. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol 1999; 21: 237-9.
19. McCloy M, Almeida A, Daly P, Vulliamy T, Roberts IAG, Dokal I. Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. Br J Haematol 2001; 112: 427-429.
20. Mac Millan ML, Weisdorf DJ, DeFor TE, Champagne MA, Auerbach AD, Wagner JE. Marked reduction in graft failure and regimen related toxicity after unrelated donor hematopoietic cell transplantation in patients with Fanconi anemia: impact of disease stage and Fludarabine. Blood 2001; 98 (Suppl 1): 670a.
21. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 186-93.
22. Deeg HJ, Socie G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386-92.
23. Zecca M, Prete A, Rondelli R et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192-1200.
24. Locatelli F, Giorgiani G, Pession A, Bozzola M. Late effects in children after bone marrow transplantation: a review. Haematologica 1993; 78: 319-328.
25. Rooney CM, Smith CA, Ng CYC et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549-1555.